These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9536956

  • 1. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
    Stanley AJ, Bouchier IA, Hayes PC.
    Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956
    [Abstract] [Full Text] [Related]

  • 2. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD.
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [Abstract] [Full Text] [Related]

  • 3. Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
    Piscaglia F, Gaiani S, Siringo S, Gramantieri L, Serra C, Bolondi L.
    Aliment Pharmacol Ther; 1998 May; 12(5):475-81. PubMed ID: 9663729
    [Abstract] [Full Text] [Related]

  • 4. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
    Sharma P, Kumar A, Sharma BC, Sarin SK.
    Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
    Escorsell A, Bordas JM, Feu F, García-Pagán JC, Ginès A, Bosch J, Rodés J.
    Gastroenterology; 1997 Nov; 113(5):1640-6. PubMed ID: 9352867
    [Abstract] [Full Text] [Related]

  • 7. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B.
    Gastroenterol Hepatol; 2000 Nov; 23(6):275-81. PubMed ID: 15324622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
    Albillos A, García-Pagán JC, Iborra J, Bandi JC, Cacho G, Pérez-Paramo M, Escorsell A, Calleja JL, Escartín P, Bosch J.
    Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
    [Abstract] [Full Text] [Related]

  • 10. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA.
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [Abstract] [Full Text] [Related]

  • 11. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
    Kong DR, Ma C, Wang M, Wang JG, Chen C, Zhang L, Hao JH, Li P, Xu JM.
    World J Gastroenterol; 2013 Jul 14; 19(26):4228-33. PubMed ID: 23864788
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL, Bangash IH, Walker J, Simpson KJ, Finlayson ND, Hayes PC.
    Gut; 1995 Jan 14; 36(1):104-9. PubMed ID: 7890211
    [Abstract] [Full Text] [Related]

  • 16. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD, Plevris JN, Redhead DN, Bouchier IA, Hayes PC.
    J Hepatol; 1994 Apr 14; 20(4):542-7. PubMed ID: 8051395
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J.
    Hepatology; 1990 Feb 14; 11(2):230-8. PubMed ID: 2307401
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.